Effect of Standardized Perioperative Dabigatran Interruption on Residual Anticoagulation Effect at the Time of Surgery or Procedure

Trial Profile

Effect of Standardized Perioperative Dabigatran Interruption on Residual Anticoagulation Effect at the Time of Surgery or Procedure

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2015 New trial record
    • 29 Oct 2015 Results published in the Journal of Thrombosis and Haemostasis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top